By Research Area

Hot products

Thrombosis & Hemostasis Research

Creative Biolabs supplies antibodies for coagulation, platelet activation, fibrin formation, and hemostasis pathway studies. Thrombosis and hemostasis antibodies can be explored through cardiovascular disease research categories with product groups for coagulation factor antibodies, platelet activation antibodies, fibrinogen antibody searches, thrombin generation markers, von Willebrand factor antibody selection, and PF4 antibody research.

Platelet Activation and Platelet-Associated Markers

Thrombosis research often begins with platelet adhesion, activation, aggregation, and granule release. Platelet activation antibodies may target CD41/ITGA2B, CD61/ITGB3, CD62P/P-selectin, GP1BA, GP6, PF4/CXCL4, thrombospondin, and other platelet-associated proteins. These targets can support flow cytometry, immunofluorescence, western blotting, and assay-development research.

Research focus	Representative antibody targets	Common research use
Platelet identity	CD41, CD61, GP1BA, GP6	Platelet lineage, adhesion, and receptor studies
Activation and granule release	CD62P, PF4/CXCL4, thrombospondin	Activation-state and secretion-related assays
Platelet-endothelium context	VWF, P-selectin, ICAM1	Adhesion and vascular interaction research

Coagulation Cascade and Thrombin Generation Targets

Coagulation factor antibodies help researchers evaluate cascade components, activation steps, and regulatory proteins. Targets may include F2/prothrombin, thrombin, F3/tissue factor, F5, F7, F8, F9, F10, F11, F12, SERPINC1/antithrombin, protein C, protein S, and related pathway markers. Thrombin generation markers are presented as research readouts, not clinical interpretation tools.

Initiation-focused panels may include tissue factor, F7, and early cascade markers.
Propagation and thrombin-generation studies may use F2, thrombin, F5, F8, F9, and F10-related targets.
Regulatory pathway studies may include antithrombin, thrombomodulin, protein C, protein S, and TFPI.
Assay planning can consider sample matrix, target state, antibody specificity, and validation conditions.

Fibrin Formation, Fibrinolysis, and Clot Structure

Fibrinogen antibody and fibrin-related target searches are central to clot-formation studies. Researchers may need antibodies against FGA, FGB, FGG, fibrin, fibrin degradation-associated markers, plasminogen, PLAT/tPA, PLAU/uPA, SERPINE1/PAI-1, and proteins involved in clot structure or fibrinolysis.

Endothelial and Hemostatic Regulation Markers

Hemostasis is not only a platelet and coagulation process; the vessel wall contributes through VWF, thrombomodulin, EPCR/PROCR, TFPI, endothelial activation markers, and anticoagulant regulation pathways. A von Willebrand factor antibody may be used in research contexts involving platelet adhesion, endothelial storage/release biology, or vascular hemostatic regulation.

Research focus	Representative antibody targets	Common research use
Endothelial hemostasis	VWF, THBD, PROCR, TFPI	Vessel-wall contribution to coagulation and anticoagulant regulation
Clot formation	Fibrinogen chains, fibrin, thrombin	Fibrin formation and clot-structure studies
Fibrinolysis	PLG, PLAT, PLAU, SERPINE1	Clot breakdown and fibrinolytic pathway research

Browse Thrombosis and Hemostasis Antibodies by Target

Researchers can browse products by platelet activation, coagulation factors, fibrin formation, fibrinolysis, endothelial hemostatic regulation, and anticoagulant pathways. Hot Products may include VWF, PF4, fibrinogen chains, thrombin, tissue factor, CD41, CD61, CD62P, antithrombin, thrombomodulin, and PAI-1.

For adjacent cardiovascular applications, compare antibody target groups across Atherosclerosis Research, Myocardial Infarction & HF Research, and Hypertension & Vascular Remodeling Research
For assay-format planning, see Cardiovascular Research Assay Routing
If you cannot find a suitable product, please contact our experts for personalized guidance.

FAQ

Which antibodies are useful for platelet activation studies?

CD41, CD61, CD62P/P-selectin, GP1BA, GP6, PF4/CXCL4, and thrombospondin are commonly considered for platelet identity, activation, adhesion, and granule-release research. The right choice depends on assay format and activation model.

How should coagulation factor antibodies be selected?

Start with the cascade step being studied. Tissue factor and F7 may support initiation-focused studies, F2/thrombin and factors V, VIII, IX, and X may support propagation questions, while antithrombin, protein C/S, TFPI, and thrombomodulin relate to regulation.

What is the difference between fibrinogen and fibrin antibody use?

Fibrinogen antibodies may detect precursor protein chains or circulating fibrinogen-related targets, while fibrin-focused antibodies are more relevant to clot structure and fibrin deposition studies. Validation details should be checked for the intended sample and assay.

Can VWF and PF4 antibodies support hemostasis research?

Yes. VWF is relevant to platelet adhesion and endothelial hemostatic regulation, while PF4/CXCL4 is commonly associated with platelet granule release and platelet activation research. Both should be used within research-use-only settings.

+ Filters

Mouse Anti-F13A1 Recombinant Antibody (CB49A) (CBMAB-CA049LY)

Compare

Target: F13A1

Host: Mouse

Antibody Isotype: IgG1

Specificity: Human

Clone: CB49A

Application*: WB, P, F